Novavax novavax.com


Public lists: Smart Money VCs (6328)

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches.

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP ...Show all

Company (IPO / Went public)

Phone: 240-268-2000

Fax:

9920 Belward Campus Drive

Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Novavax $91M Jul 24, 2008
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Novavax Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

BioVex

Woburn, Massachusetts, United States
AcquiredBioVex is a biotechnology company that develops vaccines. The company develops vaccines for the treatment of cancer and chronic infectious diseases. BioVex has two proprietary vaccine platforms; OncoVEX and ImmunoVEX, and a functional genomics platform for gene target validation in neurons and other tissues.Login to see details

Array Biopharma

Boulder, Colorado, United States
IPO / Went publicArray BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. The company is building a fully integrated, commercial-stage biopharmaceutical company that discovers, develops and markets safe and effective small molecule drugs to treat patients afflicted with cancer.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Functional influenza virus-like particles (vlps) Oct 24, 2016 May 01, 2018 Patent
Highly efficient influenza matrix (m1) proteins Oct 06, 2016 Apr 24, 2018 Patent
Functional influenza virus-like particles (vlps) Mar 09, 2017 Apr 10, 2018 Patent
Compositions comprising iscom particles and live micro-organisms Nov 05, 2015 Feb 27, 2018 Patent
Modified rsv f proteins and methods of their use Jun 04, 2015 Aug 15, 2017 Patent
See all 45 patents